MES5 Ergänzungsmodul (15 ECTS)

• 300080 VO [ en ] Symbiosis concepts and model systems (Part 2)
• 300085 SE [ en ] Interactions and Evolution of Organisms - Evolutionary Systemsbiology 2
• 300094 UE [ en ] Proteomics in Systems Biology
• 300099 SE [ en ] Advanced Topics in Evolutionary Reproductive Biology
• 300104 UE [ en ] Physiology and cell biology of marine symbionts and their hosts
• 300108 VU [ en ] Macroecology and spatial phylogenetics of animals - (Data Analysis and modelling)
• 300115 UE DNA-Barcoding - Ein Weg zur Artidentifikation in der Ökologie und Biodiversitätsforschung
• 300120 VO [ en ] Systems conditions for Evolution
• 300123 UE [ de en ] Vergleichende Morphologie, Neuroanatomie & Evolution der Cheliceraten - (Spinnentiere i.w.S.)
• 300145 UE [ de en ] Entwicklungsbiologie mariner Evertebraten in Villefranche-sur-Mer
• 300153 SE [ en ] Advanced aspects of zoological taxonomy and species concepts in theory and practice
• 300159 VO [ de en ] Conservation Genetics - Genetik in Natur- und Artenschutz - (Bereich Naturschutzgenetik)
• 300164 UE [ en ] Advanced bioinformatic analysis of single-cell data
• 300223 VO [ en ] Evolutionary Genomics and Admixture
• 300246 VU [ en ] Analysis of biological data with Python for non-bioinformaticians
• 300330 PR [ en ] ( DIGITAL ) Drivers of plant and fungal diversity: from genomes to biomes
• 300347 SE [ en ] Molecular Phylogeny and Evolution - Advanced Techniques in Molecular Microbiology, Microbial Ecology and Immunology
• 300369 UE [ en ] Genomic approaches to variation, adaptation and speciation
• 300407 UE [ de en ] KI und interdisziplinäre Forschung - Grundlagen, Möglichkeiten und Grenzen
• 300411 SE [ en ] Microbial conservation and restoration: uniting science and policy
• 300436 VO+SE [ en ] Molecular Population Genetics: making sense of sequence data
• 300627 SE [ en ] Trends in Plant Genome Evolution
• 301908 VO [ en ] Immune Resistance Mechanisms to current Cancer Therapies - Part II: Newest Experimental Designs and Approaches for the Study of novel Immunotherapy targets